A novel adsorbent of circulating bacterial toxins and cytokines: The effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia

Critical Care Medicine

Volumn 34, Issue 3, 2006, Pages 800-806

  Taniguchi, Takumi ^a   Hirai, Fumiyasu ^b   Takemoto, Yasuhiro ^a   Tsuda, Kazunobu ^a   Yamamoto, Ken ^a   Inaba, Hideo ^a   Sakurai, Hiroshi ^b   Furuyoshi, Shigeo ^b   Tani, Nobutaka ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANEKA CORPORATION   (Japan)

Author keywords

Adsorption; Cytokine; Endotoxin; Enterotoxin; Sepsis

Indexed keywords

ADSORBENT; BACTERIAL TOXIN; CELLULOSE; CYTOKINE; ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 6; ORGANIC COMPOUND; TOXIC SHOCK SYNDROME TOXIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APHERESIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; COVALENT BOND; CYTOKINE PRODUCTION; ENDOTOXEMIA; ESCHERICHIA COLI; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; HEMODIALYSIS; HEMOPERFUSION; HYPOTENSION; IN VITRO STUDY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POROSITY; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; SPECIES COMPARISON; TOXIC SHOCK SYNDROME;

EID: 33644609616     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000202449.15027.AE     Document Type: Article

References (27)

1. Wakabayashi G, Gelfard JA, Jung WK, et al: Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock like state and tissue injury in rabbits without endotoxemia: Comparison to Escherichia coli. J Clin Invest 1991; 87:1925-1935
2. Casey LC, Balk RA, Bone RC: Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778
3. Kuhns DB, Alvord WG, Gallin JI: Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in human. J Infect Dis 1995; 171:145-152
4. Natanson C, Eichenholz PW, Danner RL, et al: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169:823-832
5. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21:522-526
6. Stegmayr BG: Plasmapheresis in severe sepsis or septic shock. Blood Purif 1996; 14:94-101
7. Bengsch S, Boos KS, Nagel D, et al: Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: Clinical results of a pilot study. Shock 2005; 23:494-500
8. Reinhart K, Meier-Hellmann A, Beale R, et al: Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis. Crit Care Med 2004; 32:1662-1668
9. Vincent JL, Laterre PF, Cohen J, et al: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intraabdominal infection. Shock 2005; 23:400-405
10. Kellum JA, Song M, Venkataraman R: Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004; 32:801-805
11. Oda S, Hirasawa H, Shiga H, et al: Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro study. Blood Purif 2004; 22:530-536
12. Nakazawa R, Azuma N, Suzuki M, et al: A new treatment for dialysis-related amyloidosis with beta2-microglobulin adsorbent column. Int J Artif Organs 1993; 16:823-829
13. Tsuchida K, Takemoto Y, Nakamura T, et al: Lixelle adsorbent to remove inflammatory cytokines. Artif Organs 1998; 22:1064-1067
14. Tsuchida K, Takemoto Y, Nakatani T, et al: Adsorption of microorganism components by lixelle beads. Artif Organs 2000; 24:577-580
15. Tsuchida K, Takemoto Y, Sugimura K, et al: Adsorption of endotoxin by beta2-microglobulin adsorbent column (Lixelle): The new approach for endotoxinemia. Ther Apher 2002; 6:116-118
16. Hiyama E, Hyodo T, Kondo M, et al: Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis. Nephron 2002; 92:501-502
17. Taniguchi T, Yamamoto K, Ohmoto N, et al: Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 2000; 28:1101-1106
18. Taniguchi T, Shibata K, Yamamoto K: Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology 2001; 95:928-932
19. Taniguchi T, Kidani Y, Kanakura H, et al: Effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 2004; 32:1322-1326
20. Saotome T, Endo Y, Sasaki T, et al: A case of severe acute pancreatitis treated with CTR-001 direct hemoperfusion for cytokine apheresis. Ther Apher Dial 2005; 9:367-371
21. Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med 1997; 25:1095-1100
22. Fisher CJ Jr, Agosti JM, Opal SM, et al: Treatment of septic shock with tumor necrosis factor receptor: Fc fusion protein: The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996; 334:1697-1702
23. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1991; 328:1471-1477
24. Bone RC, Grodzin CJ, Balk RA: Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 112:235-243
25. Hack CE, Aarden LA, Thijs LG: Role of cytokines in sepsis. Adv Immunol 1997; 66:101-195
26. Moreland JG, Bailey G, Nauseef WM, et al: Organism-specific neutrophil-endothelial cell interactions in response to Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. J Immunol 2004; 172:426-32
27. Salyer JL, Bohnsack JF, Knape WA, et al: Mechanisms of tumor necrosis factor-alpha alteration of PMN adhesion and migration. Am J Pathol 1990; 136:831-841